*Funding: NIH_NIDDK

Funding Opportunities: NIH NIDDK

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), is a leading force in research funding. The institute plays a pivotal role in advancing understanding, diagnosis, treatment, and prevention of diseases and disorders within its mission areas, including diabetes, obesity, and kidney diseases. This note aims to provide a comprehensive overview of various funding opportunities provided by the NIDDK from 2023 to 2027. These initiatives target a multitude of research areas, require different clinical trial engagements, and support a wide array of researchers, from new investigators to seasoned scientists.

Key Funding Opportunities

1. Addressing the Impact of Syndemics on Health (2025)

- This funding opportunity seeks to explore the interplay between HIV, its comorbidities, and diseases within the NIDDK's mission areas. The R01 grant model supports optional clinical trials, urging the integration of multidisciplinary approaches to tackle these complex interrelations.

2. dkNET Coordinating Unit (U24, 2023)

- The NIDDK Information Network (dkNET) provides a data infrastructure to support researchers in diabetes, nephrology, and urology. The dkNET-CU aims at enhancing research networking and resource sharing, supported by a U24 award excluding clinical trials.

3. Time-Sensitive Obesity Policy Evaluation (2024)

- This initiative supports rapid-response research projects analyzing the effects of policies and programs related to obesity. Notably utilizing the R01 model, this call does not include clinical trials, emphasizing observational and model-based research instead.

4. New Investigator Gateway Awards for T1D Research (R03, 2023)

- Designed to foster collaborative type 1 diabetes (T1D) research, the Gateway Awards aid promising new investigators. This award restricts clinical trials, focusing on exploratory and foundational studies.

5. Integration of Social and Medical Care for T1D (R01, 2024)

- Encouraging innovative research to integrate social and medical care, this initiative requires clinical trials. It aims to alleviate T1D management challenges by integrating behavioral and medical approaches.

6. High Risk Multi-Center Clinical Study Cooperative Agreement (U01, 2026)

- Due for projects encompassing clinical trials, this initiative supports complex, high-risk studies that necessitate multi-center collaboration within NIDDK's disease areas.

7. Interdisciplinary Science in NIDDK Research (RC2, 2024)

- With an optional clinical trial component, this award emphasizes high-impact, interdisciplinary science. It seeks paradigm-shifting research that can broadly advance NIDDK mission areas.

8. KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00, 2025)

- Aimed at supporting promising researchers from late-stage doctoral work through the initial postdoctoral years, fostering independent research careers in kidney, urologic, and hematologic (KUH) diseases.

9. Limited Competition: NIDDK Program Projects (P01, 2024)

- Encouraging collaborative projects with potential clinical trials, this program supports integrated research from multiple disciplines addressing a significant problem within NIDDK's mission.

10. High-Risk Multi-Center Study Planning Agreements (U34, 2027)

    - These agreements support planning activities for future large-scale, high-risk clinical studies within identified mission areas, optionally including clinical trials.

Special Initiatives and Notices

Health Disparities and Equity

The NIDDK has a focused effort on exploring health disparities and health equity. Initiatives like the Notice of Special Interest (NOSI) on addressing health disparities in NIDDK diseases (2027) encourage research designed to bridge gaps in health outcomes among diverse populations.

Technological and Data Science Advancements

Efforts such as the Kidney Technology Development Research Education Program (R25, 2025) provide funding for innovative educational programs driving technology advancement in renal diseases. Moreover, the digital platform maintenance and enhancement initiative in 2023 underscores the importance of robust data science initiatives to support biomedical research.

Diversity in Research and Workforce

Significant funding is channeled towards diversifying the research workforce. Projects like the Small Grants for New Investigators’ Diversity in Health-Related Research (R21, 2024) give rise to new, diverse research talent.

Addressing Comorbidities with HIV

NIDDK collaborates with other NIH institutes like the National Heart, Lung, and Blood Institute (NHLBI) to understand and mitigate the impacts of HIV comorbidities and coinfections, represented by funding opportunities such as Priority HIV/AIDS Research within the NIDDK's Mission (R01, 2025).

Conclusion

NIDDK’s funding opportunities reflect a commitment to advancing medical research and supporting a diverse and equitable scientific community. These initiatives, spanning from foundational research to clinical trials, tackle a broad array of challenges within the institute's mission areas. By supporting interdisciplinary collaboration, leveraging technological advances, and addressing health disparities, NIDDK strives to enhance the prevention, diagnosis, and treatment of chronic diseases affecting millions globally. Researchers are encouraged to explore these opportunities to contribute to groundbreaking discoveries and public health advancements.